Recommendations are presented for the diagnostic evaluation of patients with Alzheimer disease (AD) or AD and related dementias (ADRD).
"Sandwich generation" caregivers face declines in their own mental and physical health, according to a study published online.
The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback